Strategic Alliances for Technology Transfer
The Strategic Alliances office within the Office of Policy, Communications and Strategic Alliances aims to make it easy for industry and academia to interact and partner with NCATS laboratories and scientists. The office provides a complete array of services to support NCATS technology development and partnership activities. These services include negotiating standard forms and model agreements between NCATS and outside parties, including universities, pharmaceutical companies and biotechnology companies. These agreements provide for:
- The exchange of research materials under material transfer agreements (MTAs).
- Collaborative research conducted under cooperative research and development agreements (CRADAs).
- Clinical studies to determine the safety and efficacy of new agents under clinical trial agreements (CTAs).
- Exchange of confidential information under confidential disclosure agreements (CDAs).
The Strategic Alliances office reviews employee discovery and invention reports (EIRs) and makes recommendations to NIH's Office of Technology Transfer (OTT) concerning filing of domestic and foreign patent applications. NIH OTT also assists in licensing all NCATS technologies.
NCATS Inventions Available for Licensing
Inventions made by NCATS employees are owned by the federal government. Patenting and licensing are used to help ensure the technology is fully developed, commercialized and advancing public health. View a list of NCATS patent applications available for licensing.
Technology Transfer Education
The Federal Laboratory Consortium for Technology Transfer (FLC) offers a free video tutorial on technology transfer, including an overview of the topic, considerations for federal agencies, different mechanisms for technology transfer, and the role of the FLC.
To learn more about technology transfer or to complete the Advanced Studies in Technology Transfer certificate program offered by the Foundation for Advanced Education in the Sciences (FAES), visit the FAES website.
For questions about technology transfer and partnerships, e-mail the NCATS Strategic Alliances office.
New CRADA Opportunity
On June 24, 2014, NCATS announced the availability of a new Cooperative Research and Development Agreement (CRADA) and licensing opportunity. The Center and the University of Delaware are seeking partners for the final stages of lead optimization, evaluation and pre-clinical development of a new series of small molecule inhibitors of the human USP1/UAF1 complex for the treatment of cancer. Statements of interest from potential collaborators are due by July 24, 2014. Learn more about this opportunity.
Overview of Technology Transfer
This slide presentation covers all you ever wanted to know but were afraid to ask about technology transfer.